Product NDC: | 50474-700 |
Proprietary Name: | Cimzia |
Non Proprietary Name: | certolizumab pegol |
Active Ingredient(s): | & nbsp; certolizumab pegol |
Administration Route(s): | |
Dosage Form(s): | KIT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50474-700 |
Labeler Name: | UCB, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA125160 |
Marketing Category: | BLA |
Start Marketing Date: | 20080420 |
Package NDC: | 50474-700-61 |
Package Description: | 2 KIT in 1 CARTON (50474-700-61) > 1 KIT in 1 KIT * 1 mL in 1 VIAL, GLASS * 1 mL in 1 VIAL, GLASS |
NDC Code | 50474-700-61 |
Proprietary Name | Cimzia |
Package Description | 2 KIT in 1 CARTON (50474-700-61) > 1 KIT in 1 KIT * 1 mL in 1 VIAL, GLASS * 1 mL in 1 VIAL, GLASS |
Product NDC | 50474-700 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | certolizumab pegol |
Dosage Form Name | KIT |
Route Name | |
Start Marketing Date | 20080420 |
Marketing Category Name | BLA |
Labeler Name | UCB, Inc. |
Substance Name | |
Strength Number | |
Strength Unit | |
Pharmaceutical Classes |